137 related articles for article (PubMed ID: 10337454)
1. Effects of erdosteine and its metabolites on bacterial adhesiveness.
Braga PC; Dal Sasso M; Sala MT; Gianelle V
Arzneimittelforschung; 1999 Apr; 49(4):344-50. PubMed ID: 10337454
[TBL] [Abstract][Full Text] [Related]
2. The combination of the SH metabolite of erdosteine (a mucoactive drug) and ciprofloxacin increases the inhibition of bacterial adhesiveness achieved by ciprofloxacin alone.
Dal SM; Bovio C; Culici M; Braga PC
Drugs Exp Clin Res; 2002; 28(2-3):75-82. PubMed ID: 12224380
[TBL] [Abstract][Full Text] [Related]
3. Bacterial adhesiveness: effects of the SH metabolite of erdosteine (mucoactive drug) plus clarithromycin versus clarithromycin alone.
Braga PC; Zuccotti T; Dal Sasso M
Chemotherapy; 2001; 47(3):208-14. PubMed ID: 11306790
[TBL] [Abstract][Full Text] [Related]
4. Effect of erdosteine and its metabolites on tracheobronchial mucus production and transport.
Scuri R; Giannetti P; Paesano A
Drugs Exp Clin Res; 1988; 14(11):693-8. PubMed ID: 3246214
[TBL] [Abstract][Full Text] [Related]
5. Mucolytic and antitussive effects of erdosteine.
Hosoe H; Kaise T; Ohmori K; Isohama Y; Kai H; Takahama K; Miyata T
J Pharm Pharmacol; 1999 Aug; 51(8):959-66. PubMed ID: 10504037
[TBL] [Abstract][Full Text] [Related]
6. The SH-metabolite I of erdosteine, a mucolytic drug, enhances the inhibitory effect of salbutamol on the respiratory burst of neutrophils.
Dal Sasso M; Bovio C; Culici M; Fonti E; Braga PC
Drugs Exp Clin Res; 2002; 28(4):147-54. PubMed ID: 12512232
[TBL] [Abstract][Full Text] [Related]
7. Erdosteine enhances mucociliary clearance in rats with and without airway inflammation.
Hosoe H; Kaise T; Ohmori K
J Pharmacol Toxicol Methods; 1998 Oct; 40(3):165-71. PubMed ID: 10334633
[TBL] [Abstract][Full Text] [Related]
8. Erdosteine: antitussive and anti-inflammatory effects.
Dal Negro RW
Lung; 2008; 186 Suppl 1():S70-3. PubMed ID: 18185958
[TBL] [Abstract][Full Text] [Related]
9. Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent.
Cazzola M; Page C; Rogliani P; Calzetta L; Matera MG
Drugs; 2020 Nov; 80(17):1799-1809. PubMed ID: 33025535
[TBL] [Abstract][Full Text] [Related]
10. The effect of erdosteine and its active metabolite on reactive oxygen species production by inflammatory cells.
Miyake K; Kaise T; Hosoe H; Akuta K; Manabe H; Ohmori K
Inflamm Res; 1999 Apr; 48(4):205-9. PubMed ID: 10344471
[TBL] [Abstract][Full Text] [Related]
11. The effects of erdosteine, N-acetylcysteine, and vitamin E on nicotine-induced apoptosis of pulmonary cells.
Demiralay R; Gürsan N; Erdem H
Toxicology; 2006 Feb; 219(1-3):197-207. PubMed ID: 16377052
[TBL] [Abstract][Full Text] [Related]
12. The effect of erdosteine on airway defence mechanisms and inflammatory cytokines in the settings of allergic inflammation.
Fraňová S; Kazimierová I; Pappová L; Molitorisová M; Jošková M; Šutovská M
Pulm Pharmacol Ther; 2019 Feb; 54():60-67. PubMed ID: 30502381
[TBL] [Abstract][Full Text] [Related]
13. A combination of budesonide and the SH-metabolite I of erdosteine acts synergistically in reducing chemiluminescence during human neutrophil respiratory burst.
Dal Sasso M; Culici M; Guffanti EE; Bianchi T; Fonti E; Braga PC
Pharmacology; 2005 Jun; 74(3):127-34. PubMed ID: 15753624
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the antioxidant activity of the SH metabolite I of erdosteine on human neutrophil oxidative bursts.
Braga PC; Dal Sasso M; Zuccotti T
Arzneimittelforschung; 2000 Aug; 50(8):739-46. PubMed ID: 10994158
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of metabolite I of erdosteine on the generation of nitric oxide and peroxynitrite chemiluminescence by human neutrophils.
Dal Sasso M; Culici M; Bianchi T; Fonti E; Braga PC
Pharmacology; 2004 Jul; 71(3):120-7. PubMed ID: 15161993
[TBL] [Abstract][Full Text] [Related]
16. Cefodizime: effects of sub-inhibitory concentrations on adhesiveness and bacterial morphology of Staphylococcus aureus and Escherichia coli: comparison with cefotaxime and ceftriaxone.
Braga PC; Dal Sasso M; Maci S
J Antimicrob Chemother; 1997 Jan; 39(1):79-84. PubMed ID: 9044031
[TBL] [Abstract][Full Text] [Related]
17. Erdosteine: its relevance in COPD treatment.
Moretti M
Expert Opin Drug Metab Toxicol; 2009 Mar; 5(3):333-43. PubMed ID: 19331595
[TBL] [Abstract][Full Text] [Related]
18. Dual effects of erdosteine on hemostasis via its different metabolites in young rats.
Arica V; Tutanc M; Ozturk OH; Arica S; Basarslan F; Erden ES; Oktar S; Kaya H
Hum Exp Toxicol; 2011 Oct; 30(10):1644-8. PubMed ID: 21247989
[TBL] [Abstract][Full Text] [Related]
19. Influence of enoxacin sub-MICs on the adherence of Staphylococcus aureus and Escherichia coli to human buccal and urinary epithelial cells.
Braga PC; Piatti G
Chemotherapy; 1992; 38(4):261-6. PubMed ID: 1473365
[TBL] [Abstract][Full Text] [Related]
20. Erdosteine.
Dechant KL; Noble S
Drugs; 1996 Dec; 52(6):875-81; discussion 882. PubMed ID: 8957158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
